ORBIMED ADVISORS LLC Heron Therapeutics, Inc. Transaction History

ORBIMED ADVISORS LLC portfolio value:

$4.73M
portfolio value

Heron Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase 0.00% 1.12M shares 4.73M $4.22 1.12M
Q1 2021 share Decrease -100.00% -1.19M shares -25.22M $16.21 0
Q4 2020 share 0.00% 0 shares 7.56M $21.17 1.19M
Q3 2020 share Increase +80.47% 531.42K shares 7.94M $14.82 1.19M
Q2 2020 share Increase +22.89% 123K shares 3.40M $14.71 660.42K
Q1 2020 share Increase 0.00% 537.42K shares 6.30M $11.74 537.42K
Q2 2019 share Decrease -100.00% -1.06M shares -26.12M $18.59 0
Q1 2019 share Decrease -23.66% -331.3K shares -10.19M $24.44 1.06M
Q4 2018 share Decrease -7.54% -114.2K shares -11.61M $25.94 1.40M
Q3 2018 share Increase +15.16% 199.4K shares -3.15M $31.65 1.51M
Q2 2018 share Increase +15.38% 175.3K shares 19.63M $38.85 1.31M
Q1 2018 share Increase +75.35% 489.8K shares 19.69M $27.6 1.13M
Q4 2017 share 0.00% 0 shares 1.26M $18.1 650K
Q3 2017 share 0.00% 0 shares 1.49M $16.15 650K
Q2 2017 share 0.00% 0 shares -747K $13.85 650K
Q1 2017 share Increase 0.00% 650K shares 9.75M $15 650K